Christian Weyer, EVP, Research & Development at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 697 shares at $103.16 ($68K) on 2019-03-01, disclosed to the SEC on 2019-03-01.
Scheduled sale ($68k) by EVP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.76 | 364 | $34K | 49.6% |
| 2 | $103.16 | 333 | $34K | 50.4% |
| Total | $97.73 avg | 697 | $68K | 100% |
| Filing → |
| ICPT | SELL | 2020-01-27 | $136K | — | Filing → |
| ICPT | SELL | 2019-12-30 | $390K | — | Filing → |
| ICPT | SELL | 2019-12-02 | $106K | — | Filing → |